Related Experiment Video
Updated: Aug 24, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Glibenclamide-induced acute haemolytic anaemia revealing a G6PD-deficiency
Stéphane Vinzio1, Emmanuel Andrès, Anne-Elisabeth Perrin
1Service de Médecine Interne et de Nutrition, Hôpital de Hautepierre, 67098 Strasbourg Cedex, France. stephane.vinzio@chru-strasbourg.fr
Abstract:
A 58-year-old woman was admitted at diagnosis of type 2 diabetes without keto-acidosis. Blood glucose was normalized initially with insulin. Whilst taking glibenclamide, she developed acute haemolysis. She was homozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency and had no other factors predisposing haemolysis. We reviewed the literature and discuss the relationship between glibenclamide and haemolytic crisis and between G6PD-deficiency and diabetes.
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Oral Hypoglycemic Agents: Glinides
Type I Diabetes III: Clinical Manifestations
Hyperglycemia
Hypoglycemia and Glucagon
Type I Diabetes I: Introduction